-
FDA approves Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease
SILVER SPRING, Md. — The Food and Drug Administration on Wednesday approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease, a rare disorder similar to lymphoma (cancer of the lymph nodes).
MCD causes an abnormal overgrowth of immune cells in lymph nodes and related tissues in the body. The disease usually affects adults who often suffer from fever, night sweats, weight loss and weakness or fatigue because their body’s immune system is weakened and cannot fight infections.
-
Yankee Candle hosts a garden party
SOUTH DEERFIELD, Mass. — The Yankee Candle Co. announced the launch of Dream Garden, a limited-edition collection of garden fragrances. The line was inspired by the garden parties and consists of three fragrances: Garden Time, Blue Lavender and Sweet Pink.
Garden Time evokes the scent of fresh garden herbs; Blue Lavender mimics the scent of fresh lavender sprigs; and Sweet Pink contains a blend of sweet floral nectars.